Dr. Rajesh K. Agrawal, MD

Dr. Agrawal practices at American Lung and Sleep Disorders Consultants PA in Pinellas Park, Florida.

Dr. Agrawal's NPI, 1295712602, was assigned on December 28, 2005. Dr. Agrawal graduated from Ross University School of Medicine in 1986. Dr. Agrawal holds Florida license ME68290.

Dr. Agrawal's primary practice is American Lung and Sleep Disorders Consultants PA, at 6223 66th N St, Pinellas Park, FL 33781 in Pinellas County. The practice phone is (727) 528-4900.

Dr. Agrawal's primary practice is American Lung and Sleep Disorders Consultants PA in Pinellas Park, Florida. Dr. Agrawal is also affiliated with Morton Plant Hospital. The medical group on file is American Lung & Sleep Disorders Consultants PA. Dmand AI also links Dr. Agrawal to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Agrawal practices, 6 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Agrawal's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Agrawal is board certified in pulmonary disease by the American Board of Internal Medicine. Dmand AI has Dr. Agrawal's licenses on file in 5 states: Florida, Ohio, Pennsylvania, Iowa and Tennessee.

Dmand AI lists acute respiratory failure, asthma, bronchitis, chest trauma, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, lung disease: COPD, asthma or bronchitis and lung resection among the conditions Dr. Agrawal treats.

CMS data shows 5,291 Medicare services from Dr. Agrawal across 30 procedure codes in 2024, for 550 Medicare patients. Medicare paid $366,542 for them.

CMS counts 550 Medicare patients who saw Dr. Agrawal in 2024. The largest group is 75 to 84, with 217 patients. 75% of them have copd, and 75% have high blood pressure. 33% are also on Medicaid. Their average risk score is 2.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Agrawal's median patient age at 72, with 56% women.

In 2024, Dr. Agrawal wrote 6,566 Medicare Part D claims for 956 patients. 46% of them were for generic drugs. CMS names the drug for 6,231 of them, across 48 drugs with 11 or more claims each, at $4,458,968 in total drug cost. In 2023, CMS named 5,471 claims across 44 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Agrawal for performance year 2024, reported individually. Dr. Agrawal accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Agrawal.

CMS Open Payments shows 1,315 general payments to Dr. Agrawal from 62 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 82% of the total. GlaxoSmithKline, LLC. paid the most, $193,895.

Dr. Agrawal graduated from Ross University School of Medicine in 1986.

Dr. Agrawal is in network with 16 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. HMO plans come from the most carriers, 10. Check the plan with the practice before a visit.